Publication | Closed Access
Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial
74
Citations
18
References
2019
Year
RheumatologyAutoimmune DiseaseSystemic Lupus Erythematosus TreatmentLupusSystemic TreatmentLupus NephritisImmunologySingle-centre Phase 1AutoimmunityLow-dose Interleukin-2 TherapyImmunotherapyMedicineRheumatoid Arthritis
| Year | Citations | |
|---|---|---|
Page 1
Page 1